Amgen has announced it is developing its already marketed psoriasis drug Otezla as a potential treatment for COVID-19, the respiratory disease caused by the SARS-CoV-2 coronavirus. Otezla ...
Celgene has picked up a third approval for its anti-inflammatory drug Otezla, although it won’t reap much commercial benefit from it. Otezla (apremilast)—an oral PDE4 inhibitor—has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback